The PwC healthcare practice provides professional services to leading healthcare organizations.
More about this author
WebcastHealthcare, Higher Education, and Nonprofit Series: Hot topics and technical updates impacting accounting and financial reporting - Webcast replay
7/10/15 | Healthcare
This webcast covers FASB standard setting developments that have occurred since our April webcast. We provide a refresher on accounting for various debt transactions as well as highlight new guidance in this area. We also cover developments related to FASB projects impacting not-for-profit entities, including the not-for-profit financial statement project.
- US Health Services Deals Insights - Analysis and trends in US health services activity 2014 and 2015 outlook
3/9/15 | Healthcare
In 2014, the pace of deal activity started strong and ended stronger. After the first quarter’s 9.2% increase in deal activity from the first quarter of 2013, we noted a lull in the second and third quarters’ deal pace. However, the fourth quarter of 2014 realized a 29% jump in deal volume as compared to the fourth quarter of 2013. This jump was enough to bring 2014’s total deal activity up 16.3% overall from 2013.
WebcastHealthcare, Higher Education, and Nonprofit Series - Hot topics and technical updates impacting tax reporting - Webcast replay
1/16/15 | Healthcare
You are invited to watch PwC's webcast, "Is Your Hospital in Compliance? Understanding the Final Section 501(r) Regulations", where we discuss the 501(r) mandate minimum requirements for hospitals to obtain and maintain their tax-exempt status.
- The rise of retail health insurance exchanges
9/16/14 | Healthcare
As health insurance becomes more consumer centric, employers must decide about exchanges: public, private, or none of the above. Early tremors in the market suggest a coming paradigm shift from a business-to-business model toward a business-to-consumer model of purchasing healthcare.
- MoneyTree™ Life Sciences Report
9/10/14 | Healthcare
Biotech soars to record high: Investment in biotechnology was the highest since the start of the MoneyTree data series in 1995. Biotech and medical devices industries both see year-over-year double-digit growth in investments.